医薬品情報学
Online ISSN : 1883-423X
Print ISSN : 1345-1464
ISSN-L : 1345-1464
原著
薬学部を有する大学を対象とした副作用報告に関連した薬学教育の実態調査
堀 里子土屋 雅美木﨑 速人橋口 正行佐藤 倫広目時 弘仁小原 拓眞野 成康
著者情報
ジャーナル フリー

2024 年 26 巻 3 号 p. 128-135

詳細
抄録

Objective: The collection and utilization of adverse drug reaction (ADR) reports are essential in pharmacovigilance activities. Healthcare professionals, especially pharmacists, are required to report ADRs to the regulatory authorities in Japan. The ability of pharmacists to identify ADRs, assess causality and severity, and submit ADR reports is of utmost importance. This study aimed to investigate the current status and challenges of education regarding ADR reporting in pharmacy schools in Japan.
Design: A cross-sectional survey.
Methods: A self-reported questionnaire was conducted among faculty members of 77 pharmacy schools in Japan to assess the implementation of ADR reporting system education. A separate survey was conducted among hospital and community pharmacists to understand ADR reporting-related training provided during practical training. The questionnaire included items on implementing ADR-related lectures and practical training, characteristics and innovations in such education, and opinions on ADR reporting education.
Results: Responses were obtained from 48 pharmacy schools (response rate: 62%). The implementation rates for lectures on the ADR reporting system and ADR causality assessment were 94 and 83%, respectively, typically conducted in the 3rd or 4th year. However, the implementation rate for training on completing ADR reporting forms was only 38%, with 61% of these schools providing practical exercises. The survey of hospital and community pharmacists (n=22) revealed that 82% provided training on completing ADR reporting forms, often using case studies or simulated scenarios.
Conclusion: The survey found that pharmacy schools offer lectures on ADR reporting, but there isa need for practical training to improve pharmacists’ ability to report ADRs. To enhance pharmacists’ skills in this area, there should be more collaboration between schools and training sites, and comprehensive educational programs and lifelong learning opportunities should be developed.

著者関連情報
© 日本医薬品情報学会
前の記事 次の記事
feedback
Top